Bristol-Myers Squibb (HIV R&D assets) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Bristol-Myers Squibb (HIV R&D assets) General Information

Description

Development of HIV medicines. The unit engages in the research and development of HIV medicines and performing pre-clinical trials and set discovery phases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 345 Park Avenue
  • New York, NY 10154
  • United States
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
ViiV Healthcare
Corporate Office
  • 345 Park Avenue
  • New York, NY 10154
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bristol-Myers Squibb (HIV R&D assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bristol-Myers Squibb (HIV R&D assets)‘s full profile, request access.

Request a free trial

Bristol-Myers Squibb (HIV R&D assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bristol-Myers Squibb (HIV R&D assets)‘s full profile, request access.

Request a free trial

Bristol-Myers Squibb (HIV R&D assets) FAQs

  • Where is Bristol-Myers Squibb (HIV R&D assets) headquartered?

    Bristol-Myers Squibb (HIV R&D assets) is headquartered in New York, NY.

  • What industry is Bristol-Myers Squibb (HIV R&D assets) in?

    Bristol-Myers Squibb (HIV R&D assets)’s primary industry is Buildings and Property.

  • Is Bristol-Myers Squibb (HIV R&D assets) a private or public company?

    Bristol-Myers Squibb (HIV R&D assets) is a Private company.

  • What is the current valuation of Bristol-Myers Squibb (HIV R&D assets)?

    The current valuation of Bristol-Myers Squibb (HIV R&D assets) is .

  • What is Bristol-Myers Squibb (HIV R&D assets)’s current revenue?

    The current revenue for Bristol-Myers Squibb (HIV R&D assets) is .

  • Who are Bristol-Myers Squibb (HIV R&D assets)’s investors?

    Bristol-Myers Squibb has invested in Bristol-Myers Squibb (HIV R&D assets).

  • When was Bristol-Myers Squibb (HIV R&D assets) acquired?

    Bristol-Myers Squibb (HIV R&D assets) was acquired on 22-Feb-2016.

  • Who acquired Bristol-Myers Squibb (HIV R&D assets)?

    Bristol-Myers Squibb (HIV R&D assets) was acquired by ViiV Healthcare and GSK.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »